Skip to content
Lower risk Medical device recall · FDA · Published September 27, 2023

Smith & Nephew JOURNEY II Knee Prosthesis Recall: Mislabeling Risk

Smith & Nephew recalls specific knee prostheses due to mislabeling that could lead to incorrect use. Affected models include JOURNEY II BCS CONSTRAINED ARTICULAR INSERT Size 5-6, 10 MM Left, REF 74029262. Contact for details.

🇺🇸 FDA recall #Z-0158-2024Medical deviceSmith & Nephew ›
Take action

Contact the company

Recalling firmSmith & Nephew, Inc.1450 E Brooks Rd · Memphis, TN 38116-1804
✎ GovInfoNow plain-language explainer

What happened, in plain English

Smith & Nephew is recalling a specific knee prosthesis model due to mislabeling between two similar products. This could lead to using the wrong part, which might cause improper fitting or complications during surgery. Read more at govinfonow.com/recall/57222-smith-nephew-journey-ii-knee-prosthesis-recall-mislabeling-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/57222-smith-nephew-journey-ii-knee-prosthesis-recall-mislabeling-risk · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0158-2024

Cite this page

“Smith & Nephew JOURNEY II Knee Prosthesis Recall: Mislabeling Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/57222-smith-nephew-journey-ii-knee-prosthesis-recall-mislabeling-risk. Based on FDA recall #Z-0158-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0158-2024%22&limit=1).

Why it’s dangerous

The prosthesis was mislabeled between two similar products. One was labeled as a constrained insert but packaged as an un-constrained insert, and vice versa. This could lead to using the wrong type of knee implant during surgery, potentially causing improper fitting or complications.

Who’s affected

Patients who received the JOURNEY II BCS CONSTRAINED ARTICULAR INSERT Size 5-6, 10 MM Left, REF 74029262 knee prosthesis from Smith & Nephew. Surgeons and medical staff who used this model during procedures are most at risk.

How to tell if you have this one

Check for the product name 'JOURNEY II BCS CONSTRAINED ARTICULAR INSERT Size 5-6, 10 MM Left' with reference number 74029262. The batch number is 22BM17564 and the UDI/DI code is 00885556176467.

  • Brand
    Smith & Nephew
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Worldwide distribution - US Nationwide and the country of Japan.
Recall numberProduct, codes & lotsQuantity
Z-0157-2024JOURNEY II BCS ARTICULAR INSERT, LEFT 10 MM SIZE 5-6, REF 74027262; knee prosthesis; UDI/DI 00885556178010, Batch Number 22BM1834828 units
Z-0158-2024JOURNEY II BCS CONSTRAINED ARTICULAR INSERT Size 5-6, 10 MM Left, REF 74029262; knee prosthesis; UDI/DI 00885556176467, Batch Number 22BM1756429 units
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the product name, reference number, and batch number to confirm if your knee prosthesis is affected.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Worldwide distribution - US Nationwide and the country of Japan.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 35 days after the firm started it.

1. Firm started the recall: Sep 27, 202312. FDA classified it Class II: Oct 24, 202323. Published in FDA’s Enforcement Report: Nov 1, 202332023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0158-2024 (September 27, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0158-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA